AlphAIalphai — Financial news for AI agents
SEC EDGARJUN 121 min read$MSCI

Wiechmann Andrew C. sold $272K of MSCI

Wiechmann Andrew C. (Chief Financial Officer) sold 450 shares of MSCI Inc. (MSCI) at $604.56 ($0.27M total) on 2026-06-10 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Wiechmann Andrew C.
Published Jun 12, 2026, 8:07 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jun 12, 2026, 8:14 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About alphai AI DeskScoring methodologyReport an issue
alphai market briefInsider activity
Primary signal
$MSCI
Neutral
high confidence
Mentioned
$MSCI
Relevance
3/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$MSCINeutralLow
01

Why it matters

The newest fact is the CFO’s open-market sale of 450 shares at ~$604.56/share under a pre-arranged 10b5-1 plan; no other MSCI-specific developments are provided.

02

Market read

Primarily sentiment/positioning noise rather than a fundamental catalyst.

03

What to watch

The filing does not indicate intent beyond the plan; without additional context (e.g., multiple consecutive sales), signal-to-noise is low.

Relevance 3/10Novelty 2/10Timing: Filed 2026-06-12; sale executed 2026-06-10.

Background

The article is an SEC Form 4 insider transaction disclosure for MSCI, reported from SEC EDGAR.

Company-level read

Ticker impact

$MSCINeutralHigh confidence
Context

MSCI CFO Andrew C. Wiechmann sold 450 shares (~$272K) via an open-market transaction under a pre-arranged 10b5-1 plan.

Expected impact

Low likelihood of a sustained price move; any reaction is likely muted and short-lived.

Evidence & confidence

This is a Form 4 insider sale with a stated 10b5-1 plan, and the article provides no new company-specific operational or financial catalyst.

Market effects

Sector

Minimal; insider transaction does not reset sector expectations.

Regional

None indicated.

Global

None indicated.

Counterpoint

What could challenge this read

Even 10b5-1 sales can coincide with private views on valuation or liquidity needs; traders may still watch for follow-on insider activity.

Key entities

  • issuer
    MSCI Inc.

    Company whose CFO filed the Form 4 insider sale disclosure.

  • insider
    Andrew C. Wiechmann

    MSCI CFO who sold 450 shares under a 10b5-1 plan.

Read at source← All news

Related articles

JUL 22
$MSCIMed

Transcript: MSCI Q2 2026 Earnings Conference Call

MSCI (NYSE:MSCI) reported Q2 2026 results on a conference call. The company said organic revenue growth was over 12%, adjusted EPS growth nearly 19%, and adjusted EBITDA growth 14%. It cited total run rate growth of 12%, ABF run rate growth of 25% to $948 million, and ETF-linked inflows of nearly $40 billion. MSCI repurchased $147 million of shares at about $558 average.

sahmcapital.com12 min
JUL 22
$SNDKMed

Stocks Gain as Chipmakers Rebound

Stocks rose as chipmakers and AI-infrastructure shares rebounded. The iShares Semiconductor ETF (SOXX) gained over 3%, while Sandisk (SNDK), Micron (MU), Western Digital (WDC), and others rose. Bitcoin hit a 1-month high, lifting Coinbase (COIN) and Circle (CRCL). Hasbro (HAS) reported Q2 net revenue $1.14B and raised guidance; 3M (MMM) beat EPS and lifted outlook.

yahoo.com7 min
JUL 22
$MSCIMed

MSCI-Linked ETF AUM Tops $2.8 Trillion, but Investors Still Sold the Stock - MSCI (NYSE:MSCI)

MSCI reported operating revenue of $867 million, up 12.2% year over year, slightly above expectations of $866.4 million, driven by higher recurring subscription and asset-based fees. MSCI-linked ETF AUM rose above $2.8 trillion on nearly $40 billion in Q2 inflows. Despite record inflows, MSCI shares fell about 10% Tuesday to $561.74. The company raised 2026 cash flow and expense outlooks.

benzinga.com5 min
JUL 21
$MSCIMedAI 8/10

Why MSCI Stock Is Plummeting Lower Today

MSCI shares fell about 10% to around $561.74 after the company reported Q2 results that missed Wall Street expectations, despite sales up 12% and adjusted EPS up 19%. MSCI also slightly raised 2026 expense guidance tied to integrating First Street. Investors are reacting to the earnings and guidance.

fool.com6 min
JUL 21
$MSCIMed

MSCI Q2 Earnings Call Highlights

MSCI reported Q2 results on its earnings call. CFO Andy Wiechmann said the asset-based fee run rate neared $950 million and ETF AUM linked to MSCI indexes rose to over $2.8 trillion. Management cited 17% index run rate growth, 41% recurring net new sales growth, and retention above 97%, plus Private Assets growth and AI product adoption. Sustainability and climate sales faced cancellations; guidance turned roughly zero to slightly negative.

yahoo.com6 min